Inorganic phosphorus reduces hypercalciuria during total parenteral nutrition by enhancing renal tubular calcium absorption

Journal of Parenteral and Enteral Nutrition

Volumn 22, Issue 3, 1998, Pages 142-146

  Berkelhammer, Charles ^a,b   Wood, Richard J ^a,c   Sitrin, Michael D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ADVOCATE CHRIST MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CALCITRIOL; CALCIUM; CORTICOSTEROID; GLUCOSE; LIPID; MULTIVITAMIN; MVI; PARATHYROID HORMONE; PHOSPHATE; PREDNISOLONE; TRACE ELEMENT; TRAVASOL; TRAVEMULSION; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM ABSORPTION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPERCALCIURIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE FUNCTION; MALE; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; URINARY EXCRETION;

EID: 0031925233     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607198022003142     Document Type: Article

References (42)

1. Bengoa JM, Sitrin MD, Wood RJ, et al: Amino acid-induced hypercalciuria in patients on total parenteral nutrition. Am J Clin Nutr 38:264-269, 1983
2. Wood RJ, Bengoa JM, Sitrin MD, et al: Calciuretic effect of cyclic versus continuous total parenteral nutrition. Am J Clin Nutr 41:614-619, 1985
3. Sloan GM, White DE, Brennan MF: Calcium and phosphorous metabolism during total parenteral nutrition. Ann Surg 197:1-6, 1983
4. Berkelhammer CH, Wood RJ, Sitrin MD: Acetate and hypercalciuria during total parenteral nutrition. Am J Clin Nutr 48:1482-1489, 1988
5. Klein GL, Ament ME, Slatopolsky E, et al: Urinary mineral excretion during long term total parenteral nutrition. IN Metabolic Bone Disease in Total Parenteral Nutrition, Coburn JW, Klein GL (eds). Urban & Schwarzenberg, Baltimore, 1985, pp 101-128
6. Shike M, Shils ME, Heller A, et al: Bone disease in prolonged parenteral nutrition: Osteopenia without mineralization defect. Am J Clin Nutr 44:89-98, 1986
7. Shike M, Sturtridge WC, Tam CS, et al: Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med 92:343-350, 1980
8. Klein GL: Parenteral nutrition: Effect on bone and mineral homeostasis. Annu Rev Nutr 11:93-119, 1991
9. De Vernjou MC, Messing B, Modrowski D, et al: Multifactorial low-remodeling bone disease during cyclic total parenteral nutrition. J Clin Endocrinol Metab 60:109-113, 1985
10. Harrison JE, Jeejeebhoy KN, Track NS: The effect of total parenteral nutrition on bone mass. IN Metabolic Bone Disease in Total Parenteral Nutrition, Coburn JW, Klein GL (eds). Urban & Schwarzenberg, Baltimore, 1985, pp 53-61
11. Honasoge M, Rao DS: Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opinion Rheumatol 7:249-254, 1995
12. Lipkin EW, Ott SM, Chesnut CH III, et al: Mineral loss in the parenteral nutrition patient. Am J Clin Nutr 47:515-523, 1988
13. Chu RC, Barkowski SM, Buhac J: Small bowel resection-associated urinary calcium loss in rats on long-term total parenteral nutrition. JPEN 14:64-67, 1990
14. Klein GL, Coburn JW: Total parenteral nutrition and its effects on bone metabolism. Crit Rev Clin Lab Sci 31:135-167, 1994
15. Larchet M, Garabedian M, Bourdeau A, et al: Calcium metabolism in children during long-term total parenteral nutrition: The influence of calcium, phosphorus, and vitamin D intakes. J Pediatr Gastroenterol Nutr 13:367-375, 1991
16. Verhage AH, Cheong WK, Allard JP, et al: Increase in lumbar spine bone mineral content in patients on long-term parenteral nutrition without vitamin D supplementation. JPEN 19:431-436, 1995
17. Koo WWK: Parenteral nutrition-related bone disease. JPEN 16:386-94, 1992
18. Wood RJ, Sitrin MD, Cusson GJ, et al: Reduction of TPN-induced urinary calcium loss by increasing the phosphorus in the TPN prescription. JPEN 10:188-190, 1986
19. Wood RJ, Sitrin MD, Rosenberg IH: Effect of phosphorus on endogenous calcium losses during total parenteral nutrition. Am J Clin Nutr 48:632-636, 1988
20. Lau K, Goldfarb S, Goldberg M, et al: Effects of phosphate administration on tubular calcium transport. J Lab Clin Med 99:317-324, 1982
21. Reid IR: Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 30:83-103, 1989
22. Endres DB, Villanueva R, Sharp CF, et al: Measurement of parathyroid hormone. Endocrinol Metab Clin North Am 18:611-629, 1989
23. Reinhardt TA, Horst RL, Orf JW, et al: A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: Application to clinical studies. J Clin Endocrinol Metab 58:91-98, 1984
24. Haddad JG, Chyu KJ: Competitive protein-binding assay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 33:992-995, 1971
25. Chessex P, Pineault M, Zebiche H, et al: Calciuria in parenterally fed preterm infants: Role of phosphorus intake. J Pediatr 107:794-796, 1985
26. Vileisis RA: Effect of phosphorus intake in total parenteral nutrition infusates in premature neonates. J Pediatr 110:586-590, 1987
27. Aiken G, Lenney W: Calcium and phosphate content of intravenous feeding regimens for very low birthweight infants. Arch Dis Child 61:495-501, 1986
28. Hegsted M, Schuette SA, Zemel MB, et al: Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake. J Nutr 111:553-562, 1981
29. Portale AA, Halloran BP, Morris RC Jr: Physiologic regulation of serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 83:1494-1499, 1989
30. Portale AA, Halloran BP, Murphy MM, et al: Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 77:7-12, 1986
31. Anderson GH, Draper HH: Effect of dietary phosphorus on calcium metabolism in intact and parathyroidectomized adult rats. J Nutr 102:1123-1132, 1972
32. 2 vitamin D concentrations in healthy men. Kidney Int 25:571-575, 1984
33. Smith DA, Nordin BEL: The effect of a high phosphorus intake on total and ultrafilterable plasma calcium and on phosphate clearance. Clin Sci 26:479-486, 1964
34. Reiss E, Canterbury JM, Bercovitz MA, et al: The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 44:2146-2149, 1970
35. Spencer H, Kramer C, Rubio N, et al: The effect of phosphorus on endogenous fecal calcium excretion in man. Am J Clin Nutr 43:844-851, 1986
36. Knowles JB, Cusson GJ, Smith M, et al: Pulmonary deposition of calcium phosphate crystals as a complication of home total parenteral nutrition. JPEN 13:209-213, 1989
37. Hill SE, Heldman LS, Goo EDH, et al: Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution. JPEN 20:81-87, 1996
38. Dunham B, Marcuard S, Khazanie PG, et al: The solubility of calcium and phosphorus in neonatal total parenteral nutrition solutions. JPEN 15:608-611, 1991
39. MacKay MW, Fitzgerald KA, Jackson D: The solubility of calcium and phosphate in two specialty amino acid solutions. JPEN 20:63-66, 1996
40. Raupp P, Kries RV, Pfahl HG, et al: Glycero- vs glucose-phosphate in parenteral nutrition of premature infants: A comparative in vitro evaluation of calcium/phosphorus compatibility. JPEN 15:469-473, 1991
41. Hanning RM, Atkinson SA, Whyte RK: Efficacy of calcium glycerophosphate vs conventional mineral salts for total parenteral nutrition in low-birth-weight infants: A randomized clinical trial. Am J Clin Nutr 54:903-908, 1991
42. Costello I, Powell C, Williams AF: Sodium glycerophosphate in the treatment of neonatal hypophosphataemia. Arch Dis Child 73:F44-45, 1995